Treatment Protocol for Use of Anascorp™ in Patients With Scorpion Sting Envenomation
Status:
Completed
Trial end date:
2010-09-01
Target enrollment:
Participant gender:
Summary
This treatment protocol will enable therapeutic use of Anascorp in the management of systemic
manifestations of scorpion sting envenomation, in patients for whom antivenom would otherwise
be unavailable. The working hypotheses are as follows:
1. The investigational antivenom is safe as treatment of scorpion sting envenomation.
2. The investigational antivenom is effective as treatment of scorpion sting envenomation.